comparemela.com

Brian Lian News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Viking Therapeutics Reports Q1 Results: An Exceptional Period Says CEO - Viking Therapeutics (NASDAQ:VKTX)

Viking Therapeutics reports quarterly losses of 26 cents per share which beat the analyst consensus estimate of losses of 28 cents by 7.14%. Research and development expenses were $24.1 million for the first quarter, compared to $11 million for the same period in 2023.

Therapeutics incViking therapeuticsBrian lianGoing on with advanced micro devicesBenzinga pro

Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLas vegasObesity health forumTherapeutics incPrnewswire viking therapeutics incDrug administrationLigand pharmaceuticals incorporatedExchange commissionBofa securities health care conferenceTherapeutics reports first quarterProvides corporateFrom phasePlacebo adjusted weight lossFrom baselinePromising safety

Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735

/PRNewswire/ Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies.

Ligand pharmaceuticals incorporatedDrug administrationTherapeutics incPlacebo adjusted mean weight lossObserved afterDay studyFlow ratesRelated adverseObesity plannedCall scheduledViking therapeuticsBrian lianBody weight followingDaily dosingRelated adverse events followingLigand pharmaceuticals

Viking Therapeutics stock gains on data for weight loss drug

Viking Therapeutics stock gains on data for weight loss drug
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Ventyx biosciencesRhythm pharmaceuticalsViking therapeuticsBrian lianNovo nordiskEli lilly

Viking Therapeutics Soars After Reporting Positive Results From Oral Weight-Loss Drug

Viking Therapeutics shares jumped after the company reported its experimental oral weight-loss drug showed positive results in an early trial.

Viking therapeuticsExecutive officerBrian lianNovo nordisk

vimarsana © 2020. All Rights Reserved.